![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Address
Altitude Life Science Ventures
175 Mercado Street
Durango, CO 81301
United States
Website
Recent investment activity
KANDO id: 39581
Corporate information
Registration country
Fund terms
Fund manager
Fund type
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 13 of 13| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Arete Therapeutics Inc | A biotechnology company, engages in the discovery and development of drugs to treat diabetes, and inflammatory and cardiovascular diseases. | N/A | |||
|
|
Ikaria Inc | Developer of innovative therapeutics and interventions to meet the significant needs of critically ill patients | N/A | |||
|
|
KYTHERA Biopharmaceuticals Inc | Series D | ||||
|
|
KYTHERA Biopharmaceuticals Inc | Series C | ||||
|
Cambrios Technologies Corp (Cambrios Advanced Materials) | Developer of proprietary nanostructured electronic materials for the display industry | Series D Initial investment | |||
|
Constellation Pharmaceuticals Inc | Rapidly Advancing Emerging Epigenetics Research to Develop Novel Oncology Therapeutics | Series B Follow-on investment | |||
|
|
Constellation Pharmaceuticals Inc | Rapidly Advancing Emerging Epigenetics Research to Develop Novel Oncology Therapeutics | Series A Initial investment | |||
|
|
KYTHERA Biopharmaceuticals Inc | Series B | ||||
|
|
Limerick BioPharma Inc | Series C | ||||
|
|
Limerick BioPharma Inc | Venture | ||||
|
Siluria Technologies Inc | Maker of nanotechnology-enabled products for cleantech-related markets | Series C | |||
|
|
Siluria Technologies Inc | Maker of nanotechnology-enabled products for cleantech-related markets | Series B | |||
|
|
Siluria Technologies Inc | Maker of nanotechnology-enabled products for cleantech-related markets | Series A |